<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04548297</url>
  </required_header>
  <id_info>
    <org_study_id>2020-122</org_study_id>
    <nct_id>NCT04548297</nct_id>
  </id_info>
  <brief_title>Clinical Factors Associated With Position Sense in Patients With Multiple Sclerosis</brief_title>
  <official_title>Clinical Factors Associated With Position Sense in Patients With Multiple Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gazi University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gazi University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sensory impairment is an important problem for patients with Multiple Sclerosis (MS).&#xD;
      Although there is no complete loss of sensation in patients, 80% of patients have a&#xD;
      significant sensory impairment. The sensory system plays an important role in providing the&#xD;
      feedback required to perform motor tasks. Cutaneous sensation, especially in the sole of the&#xD;
      foot, is very important in maintaining balance and gait. There are studies showing decreased&#xD;
      foot sole sensation in MS patients. Another sensation that is important during motor tasks is&#xD;
      the proprioceptive sensation.&#xD;
&#xD;
      The aim of this study is to examine the relationship between the sensation of foot sole and&#xD;
      joint position, clinical features, attention, fatigue, body awareness and physical activity&#xD;
      level in patients with MS.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with MS between 0-5,5 score according to the Extended Disability Status Scale (EDSS)&#xD;
      and healthy individuals of similar age and sex to patients will be included in the study. The&#xD;
      sensation of foot sole, joint position sensation, attention, fatigue, body awareness, and&#xD;
      physical activity level will be evaluated.&#xD;
&#xD;
      The investigators will use t-tests to compare for quantitative variables and chi-square for&#xD;
      the categorical variables between groups. In addition, the investigators will examine the&#xD;
      correlations between the sensation of the foot sole, joint position sensation, attention,&#xD;
      fatigue, body awareness, and physical activity level using Pearson bivariate correlations.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 5, 2020</start_date>
  <completion_date type="Anticipated">September 14, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 14, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Light touch-pressure sensation</measure>
    <time_frame>10 minutes</time_frame>
    <description>Light touch-pressure sensation will be assessed using a full Semmes-Weinstein Monofilament (SWM) test kit (North Coast Medical, San Jose, CA, USA).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vibration sensation</measure>
    <time_frame>10 minutes]</time_frame>
    <description>Duration of vibration sensation will be measured using 128-Hz frequency tuning fork (Elcon1 Medical Instruments, Tuttlingen, Germany).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>position sensation of knee joint</measure>
    <time_frame>5 minutes</time_frame>
    <description>Open kinetic chain position of both knees will be evaluated using a Dualer IQ Digital Inclinometer (J-Tech Medical, Midvale, UT, USA).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee proprioception</measure>
    <time_frame>10 minutes</time_frame>
    <description>Knee proprioception will be evaluated with the active joint reposition test using the isokinetic system (Cybex Norm, Humac, CA, USA).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fatigue Severity</measure>
    <time_frame>5 minutes</time_frame>
    <description>In the Fatigue Severity Scale (FSS), participants are asked to rate their fatigue level between 1 and 7 in the 9 statements (including motivation, exercise, physical functioning, carrying out duties, and interfering with work, family, or social life) during the last week.The minimum score possible is 9 and the highest is 63. The higher score indicates more severe fatigue.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>attention</measure>
    <time_frame>5 minutes</time_frame>
    <description>Attention will be evaluated by Trail Making Test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Activity</measure>
    <time_frame>10 minutes</time_frame>
    <description>Physical Activity will be evaluated using International Physical Activity Questionnaires (IPAQ). The IPAQ measures vigorous-intensity activity, moderate-intensity activity, and walking activity levels by calculating physically active time in regard to the number of days and average time per day in the last week. The activity levels are represented as a Metabolic Equivalent of Tasks (METs) which is the energy expended during sitting at rest. The total score of IPAQ indicates a low physical activity of fewer than 600 MET-minutes per week, moderate physical activity of more than 600 MET-minutes per week, and a high level of physical activity of more than 3000 MET-minutes per week. The higher score indicates a greater physical activity level of the person.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Awareness</measure>
    <time_frame>5 minutes</time_frame>
    <description>The Body Awareness Questionnaire is an 18-item scale designed to assess self-reported attentiveness to normal non-emotive body processes, specifically, sensitivity to body cycles and rhythms, ability to detect small changes in normal functioning, and ability to anticipate bodily reactions. Each item is rated ranging from 1 (totally agree) to 7 (totally disagree). The minimum score possible is 18 and the highest is 126. The higher score indicates more awareness of the body.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>Patients with Multiple Sclerosis</arm_group_label>
    <description>MS patients (EDSS: 0-5,5)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy group</arm_group_label>
    <description>Healthy individuals without chronic disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Assessment</intervention_name>
    <description>Assessments of foot sole sensation, joint position sensation, attention, fatigue, body awareness, and physical activity level</description>
    <arm_group_label>Healthy group</arm_group_label>
    <arm_group_label>Patients with Multiple Sclerosis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        ambulatory sample&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18-65 years of age&#xD;
&#xD;
          -  Having a diagnosis of &quot;Multiple Sclerosis&quot;&#xD;
&#xD;
          -  Relapse free in the last 3 mounts&#xD;
&#xD;
          -  Ambulatory status (Expanded Disability Status Scale score ≤ 6 )&#xD;
&#xD;
          -  No diagnosis of depression&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any cardiovascular, orthopedic, visual, and hearing problems that may affect the&#xD;
             results of the research&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cagla Ozkul</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gazi University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cagla Ozkul, Phd</last_name>
    <phone>+905059145532</phone>
    <email>caglaozkul@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Gazi University</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cagla Ozkul</last_name>
      <email>caglaozkul@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Cagla Ozkul</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Sanders EA, Arts RJ. Paraesthesiae in multiple sclerosis. J Neurol Sci. 1986 Jul;74(2-3):297-305.</citation>
    <PMID>3734839</PMID>
  </reference>
  <reference>
    <citation>Merchut MP, Gruener G. Quantitative sensory threshold testing in patients with multiple sclerosis. Electromyogr Clin Neurophysiol. 1993 Mar;33(2):119-24.</citation>
    <PMID>8449168</PMID>
  </reference>
  <reference>
    <citation>Kars HJ, Hijmans JM, Geertzen JH, Zijlstra W. The effect of reduced somatosensation on standing balance: a systematic review. J Diabetes Sci Technol. 2009 Jul 1;3(4):931-43. Review.</citation>
    <PMID>20144343</PMID>
  </reference>
  <reference>
    <citation>Eils E, Behrens S, Mers O, Thorwesten L, Völker K, Rosenbaum D. Reduced plantar sensation causes a cautious walking pattern. Gait Posture. 2004 Aug;20(1):54-60.</citation>
    <PMID>15196521</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>September 7, 2020</study_first_submitted>
  <study_first_submitted_qc>September 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 14, 2020</study_first_posted>
  <last_update_submitted>July 26, 2021</last_update_submitted>
  <last_update_submitted_qc>July 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gazi University</investigator_affiliation>
    <investigator_full_name>Cagla Ozkul</investigator_full_name>
    <investigator_title>Research Assistant</investigator_title>
  </responsible_party>
  <keyword>Multiple Sclerosis</keyword>
  <keyword>sensation</keyword>
  <keyword>fatigue</keyword>
  <keyword>physical activity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

